TipRanks
Incyte Corp (MX:INCY)
:INCY
Mexico Market
INCY
Incyte
RESEARCH TOOLSreports

Incyte (INCY) Stock News & Sentiment

0 Followers
Incyte’s KRAS G12D Lead Supports Undervalued Upside as Kapoor Reiterates Buy and Maintains $152 Price Target
Premium
Ratings
Incyte’s KRAS G12D Lead Supports Undervalued Upside as Kapoor Reiterates Buy and Maintains $152 Price Target
3d ago
INCY
Incyte: Atebrioz Approval and KRAS Pipeline Upside Drive Buy Rating; Price Target Raised to $152
Premium
Ratings
Incyte: Atebrioz Approval and KRAS Pipeline Upside Drive Buy Rating; Price Target Raised to $152
4d ago
INCY
AFLAC, CME, Incyte, Box, Five Below Insider Shake-Up
Premium
Weekend Updates
AFLAC, CME, Incyte, Box, Five Below Insider Shake-Up
13d ago
AFL
BOX
Incyte Reaches CMS Pact on Jakafi Medicaid Pricing
Premium
Company Announcements
Incyte Reaches CMS Pact on Jakafi Medicaid Pricing
1M ago
8K
INCY
Buy Rating Reaffirmed on Incyte as ‘734 Pancreatic Cancer Data Looms; 12-Month Price Target Reiterated at $150
Premium
Ratings
Buy Rating Reaffirmed on Incyte as ‘734 Pancreatic Cancer Data Looms; 12-Month Price Target Reiterated at $150
1M ago
INCY
KDP, Ultragenyx, Incyte, ProQR, Aurinia Trending With Analysts
Premium
Weekend Updates
KDP, Ultragenyx, Incyte, ProQR, Aurinia Trending With Analysts
1M ago
KDP
AUPH
Incyte Target Unchanged at $150 as Kapoor Reiterates Buy on Strong Early KRAS G12D Pancreatic Cancer Data
Premium
Ratings
Incyte Target Unchanged at $150 as Kapoor Reiterates Buy on Strong Early KRAS G12D Pancreatic Cancer Data
1M ago
INCY
More MX:INCY News >

INCY News on the Web

FDA Expands Lilly's Olumiant Approval To Adolescents With Severe Alopecia Areata
rttnews
Bullish
Incyte (INCY) Gets a Hold from Bernstein
TipRanks News
Neutral
FDA approves Incyte’s Atebrioz for fibrodysplasia ossificans progressiva
TipRanks News
Bullish
Incyte Expands OPZELURA Partnership With Specialised Therapeutics In Australia
rttnews
Bullish
Specialised Therapeutics expands partnership with Incyte to include Opzelura
TipRanks News
Bullish
AFLAC, CME, Incyte, Box, Five Below Insider Shake-Up
TipRanks News
Bearish
Incyte Corp at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus News
Neutral
Incyte Corp at Cantor Global Healthcare Conference Transcript
GuruFocus News
Neutral

News Score - Last 7 Days

Very Positive
MX:INCY
Sector Average
Media Buzz
This Week13 articles
Weekly Average5.25 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MX:INCY’s Media Buzz Sentiment?
13 articles about MX:INCY were published this week. In an average week, 5.25 articles are published.
    What is MX:INCY’s weekly average amount of articles?
    In an average week, 5.25 articles about MX:INCY are published.
      What is MX:INCY’s News Sentiment?
      100% of articles about MX:INCY were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        HUMHumana
        ACETAdicet Bio
        ZYMEZymeworks
        RHHBYRoche Holding
        QTTBQ32 Bio
        Showing the stocks with the most bullish news sentiment over the past week